Phase I dose escalation trial of the novel proteasome inhibitor carfilzomib in patients with relapsed chronic lymphocytic leukemia and small lymphocytic lymphoma
卡非佐米(一种新型蛋白酶体抑制剂)治疗复发性慢性淋巴细胞白血病和小淋巴细胞淋巴瘤患者的 I 期剂量递增试验
期刊:Leukemia & Lymphoma
影响因子:2.2
doi:10.3109/10428194.2015.1014368
Awan, Farrukh T; Flynn, Joseph M; Jones, Jeffrey A; Andritsos, Leslie A; Maddocks, Kami J; Sass, Ellen J; Lucas, Margaret S; Chase, Weihong; Waymer, Sharon; Ling, Yonghua; Jiang, Yao; Phelps, Mitch A; Byrd, John C; Lucas, David M; Woyach, Jennifer A